OraQuick HCV Controls coming soon quality management that conforms to

quality management that conforms to ISO 9001 and ISO 13485

INSTRUCTIONS FOR USE - External Controls

ASTM D5511 and is manufactured in accordance with a

and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests

OraQuick HCV Controls coming soon quality management that conforms toThe OraQuick HCV Rapid Antibody Test Kit Controls are human plasma based reagents. The Kit Controls are specifically formulated and manufactured to ensure proper performance of the test. The HCV Positive Control will produce a reactive reddish purple line at the Test (T) Zone. The OraQuick HCV test is FDA approved for detecting HCV antibodies in fingerstick and venipuncture whole blood. This simple platform enables healthcare providers to deliver an